EuroPCR 2018
Details
Date
- America/New_York
Alaide Chieffo
Works at San Raffaele Hospital, Milan, Lombardia, Italy. Features in 6 videos on Wondr Medical....
Read MoreWorks at San Raffaele Hospital, Milan, Lombardia, Italy. Features in 6 videos on Wondr Medical. Alaide Chieffo generally speaks on Bifurcation, Left Main Stem (LMS), Intravascular Ultrasound (IVUS), Coronary Optical Coherence Tomography (OCT), and Covid-19.
Show LessAzeem Latib
Works at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical....
Read MoreWorks at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical. Azeem Latib generally speaks on Bioresorbable Vascular Scaffold (BVS), Drug Eluting Stents (DES), Intravascular Ultrasound (IVUS), Bifurcation, and Intracoronary Imaging.
Show LessBarry Hennigan
Barry Hennigan is a consultant cardiologist at Golden Jubilee National Hospital, Clydebank, UK.
Read MoreBarry Hennigan is a consultant cardiologist at Golden Jubilee National Hospital, Clydebank, UK.
Show LessCaroline Kleinecke
Caroline Kleinecke is a cardiologist at Klinikum Lichtenfels, Lichtenfels, Germany.
Read MoreCaroline Kleinecke is a cardiologist at Klinikum Lichtenfels, Lichtenfels, Germany.
Show LessDavid Kandzari
Dr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service...
Read MoreDr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology of the Piedmont Heart Institute; and Chief Scientific Officer for Piedmont Healthcare in Atlanta, Georgia. Dr. Kandzari specializes in cardiovascular disease, peripheral arterial disease and interventional cardiology. A graduate of Duke University School of Medicine, he completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. Dr. Kandzari is the former Director of Interventional Cardiology Research at the Scripps Clinic in La Jolla, California. Before joining the Scripps faculty, he also served as Chief Medical Officer for the Cordis Corporation, a Johnson & Johnson Company. He has also served as a Medical Officer for the Center for Devices and Radiological Health for the United States Food and Drug Administration. Board certified by the American Board of Internal Medicine and its subspecialty Board of Cardiovascular Disease and Board of Interventional Cardiology, Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 400 studies, book chapters and scientific reviews, and has delivered more than 700 lectures, both nationally and internationally, on a variety of issues related to both interventional and general cardiology. Dr. Kandzari has been consecutively voted as one of Atlanta's Top Doctors by Atlanta Magazine from 2011 to 2021, and is peer-nominated in the top 1% of cardiologists by U.S News and World Report.
Show LessElmir Omerovic
Elmir Omerovic is a cardiologist at University of Gothenburg, Sweden.
Read MoreElmir Omerovic is a cardiologist at University of Gothenburg, Sweden.
Show LessFelix Mahfoud
Professor Felix Mahfoud is an Associate Professor and senior physician of Internal Medicine and...
Read MoreProfessor Felix Mahfoud is an Associate Professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital, and Affiliate/Visiting Professor Harvard-MIT Biomedical Engineering, Institute of Medical Engineering and Science, Cambridge, US. Professor Mahfoud completed training in Cardiology and Interventional Cardiology at the Department for Internal Medicine III, Saarland University Hospital, Germany in 2014. Since 2017, he has served as Vice Chairman of the ‘Working Group on Interventional Hypertension Treatment’ for the European Society of Hypertension, and as a Committee Member of the 2018 Hypertension Guidelines.
Show LessGeorg Nickenig
Georg Nickenig is an interventional cardiologist at University of Bonn, Germany.
Read MoreGeorg Nickenig is an interventional cardiologist at University of Bonn, Germany.
Show LessGiulio Stefanini
Giulio Stefanini is a cardiologist at Instituto Clinico Humanitas, Milano, Italy.
Read MoreGiulio Stefanini is a cardiologist at Instituto Clinico Humanitas, Milano, Italy.
Show LessHasan Jilaihawi
Works at Cedars-Sinai Heart Institute, Los Angeles, CA, USA. Features in 4 videos on Wondr...
Read MoreWorks at Cedars-Sinai Heart Institute, Los Angeles, CA, USA. Features in 4 videos on Wondr Medical. Hasan Jilaihawi generally speaks on Transcatheter Aortic Valve Implantation (TAVR / TAVI), Cardiac Valves, Cardiovascular Surgery – Valves, Trans Mitral Valve Implantation (TMVR), and Mitral.
Show LessJonathan Hill
Consultant Interventional Cardiologist and Revascularisation Group Chair at Royal Brompton...
Read MoreConsultant Interventional Cardiologist and Revascularisation Group Chair at Royal Brompton Hospital, London. His clinical focus is on use of intravascular imaging in complex PCI , CTO and cardiogenic shock. His clinical research interests focus on optical coherence tomography, calcific coronary disease and percutaneous ventricular support. Dr Hill was global co-chief investigator for the DISRUPT CAD III study and has served as UK principal investigator for multiple interventional trials. He has served as a CTO and complex PCI proctor on a global basis and works closely with OPTIMA to focus on the development of OPTIMAL PCI. He is the founding co-director of the Complete Revascularisation (CoRe) meetings held every year in London.
Show LessJoost Daemen
Joost Daemen is an interventional cardiology at Thorax Centre Erasmus MS, Rotterdam, The...
Read MoreJoost Daemen is an interventional cardiology at Thorax Centre Erasmus MS, Rotterdam, The Netherlands.
Show LessJose Luis Navia
Jose Luis Navia is a cardiothoracic surgeon at Cleveland Clinic, Weston, Florida, USA.
Read MoreJose Luis Navia is a cardiothoracic surgeon at Cleveland Clinic, Weston, Florida, USA.
Show LessJurrien Ten Berg
Dr Jur ten Berg is the Director of the Cardiology Training Program and Head of the St Antonius...
Read MoreDr Jur ten Berg is the Director of the Cardiology Training Program and Head of the St Antonius Center for Platelet Function Studies, at the St Antonius Hospital, the Nether-lands. Dr ten Berg received his medical degree from the University of Utrecht, the Nether-lands before taking up a residency in cardiology at St Antonius Hospital. He did his PhD at the University of Nijmegen on Oral Anticoagulation in Percutanous Coronary Inter-vention (promotor Prof Verheugt). He recently read for Master of Science in Health Economics at the London School of Economics, the UK. His areas of expertise are acute coronary syndrome, antithrombotic treatment and interventional cardiology. He has published around 350 peer-reviewed publications (Pubmed). He is actively involved in research projects in the fields of antiplatelet therapy, PCI, TA-VI, anticoagulation, stent thrombosis, pharmacogenetics, pre-hospital triage of patients with non-ST-elevation ACS and long-term follow up of aortic valve surgery. He is the PI of several trials amongst them the WOEST, POPular, POPular genetics, POPular TAVI, POPular CABG, POPular age.
Show LessJustin Davies
Dr Justin Davies is a honorary interventional cardiologist at Hammersmith Hospital, Imperial...
Read MoreDr Justin Davies is a honorary interventional cardiologist at Hammersmith Hospital, Imperial College NHS Trust, London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents, he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies).
Show LessLaura Mauri
Works at Brigham and Women's Hospital, Boston, MA, USA. Features in 1 video on Wondr Medical....
Read MoreWorks at Brigham and Women's Hospital, Boston, MA, USA. Features in 1 video on Wondr Medical. Laura Mauri generally speaks on Anti-Platelet Drugs and Drug Eluting Stents (DES).
Show LessLuca Testa
Luca Testa, MD, PhD, is an Interventional Cardiologist at the IRCCS Policlinico S. Donato in...
Read MoreLuca Testa, MD, PhD, is an Interventional Cardiologist at the IRCCS Policlinico S. Donato in Milan, (Italy) where he works as Head of the Coronary Revascularization Unit and Head of the Clinical Research Unit within the Department of Cardiology. He is also Contract Professor of Cardiology for the International MD program at the “Vita e Salute” University of San Raffaele Hospital in Milan, Italy. He has published more than 200 peer reviewed articles, covering several subjects, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Testa+L+%5BAu%5D), especially in the field of transcatheter aortic valve replacement. With the manuscripts he authored/co-authored, he provided a significant contribution to the widespread diffusion of the TAVR technologies. He is also involved as Academic Editor, Section Editor and Member of the Board of several peer-reviewed journals. He is current faculty for many international congresses including TCT and PCR. He is medical proctor for TAVR, CTOs, Coronary Imaging, and Coronary Physiology both in Europe and Middle East/Asia.
Show LessMartin Rothman
An industry at Medtronic. Features in 1 video on Wondr Medical. Martin Rothman generally speaks...
Read MoreAn industry at Medtronic. Features in 1 video on Wondr Medical. Martin Rothman generally speaks on Drug Eluting Stents (DES).
Show LessMatthew Price
Matthew Price, MD, is Director of the Cardiac Catheterization Laboratory and a member of the...
Read MoreMatthew Price, MD, is Director of the Cardiac Catheterization Laboratory and a member of the Division of Cardiovascular Diseases at Scripps Clinic, in La Jolla, California. Dr Price earned his medical degree from the University of California, Los Angeles (UCLA) School of Medicine and completed his internship and residency in internal medicine at the UCLA Center for Health Sciences. He subsequently completed a fellowship in Cardiovascular Diseases at Cedars-Sinai Medical Center in Los Angeles, where he held the position of Chief Fellow. Dr Price completed his training in interventional cardiology at Scripps Clinic, in La Jolla, California. Dr Price’s clinical and research focus includes interventional approaches to structural heart and coronary disease. He has led several clinical trials in PCI, and currently serves on the Steering and/or Executive committee of clinical trials evaluating antiplatelet therapy, novel drug-eluting stents, intravascular imaging, and left atrial appendage closure. He is a member of the Steering Committee of the ACC NCDR Left Atrial Appendage Occlusion (LAAO) registry. He has been twice awarded the Scripps Clinic Chairman’s Award for Research in Medicine. Dr Price serves as Editor-in-Chief of Interventional Cardiology Clinics and is a Section Editor for the Journal of the American College of Cardiology, He has authored or co-authored more than 140 peer-reviewed manuscripts, including publications in the New England Journal of Medicine, JAMA, the European Heart Journal, Circulation, and the Journal of the American College of Cardiology. He is also Editor of the seminal text-book, “Coronary Stenting”.
Show LessNicolas Van Mieghem
Nicolas Van Mieghem is the Clinical Director of Interventional Cardiology and Professor of...
Read MoreNicolas Van Mieghem is the Clinical Director of Interventional Cardiology and Professor of Interventional Cardiology at the Thoraxcenter, Erasmus University Medical Center, Rotterdam. He obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent Fellowships in interventional cardiology in at Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, United States and Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands, he joined the senior staff of the department of interventional cardiology in the Thoraxcenter in February 2010. Professor Van Mieghem’s academic interest is in complex (calcified) coronary lesions, mechanical circulatory support and structural heart interventions. He obtained a PhD based upon his research in transcatheter valve therapies. Professor Van Mieghem is involved in the percutaneous coronary interventions and structural heart program. Professor Van Mieghem has published and co-authored over 400 scientific papers in peer-reviewed journals. He is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and the American College of Cardiology.
Show LessPanagiotis Xaplanteris
Panagiotis Xaplanteris is a cardiologist at CHU Saint-Pierre, Brussels, Belgium.
Read MorePanagiotis Xaplanteris is a cardiologist at CHU Saint-Pierre, Brussels, Belgium.
Show LessPatrick Serruys
Prof Patrick W. Serruys with respected h-index – 183 is a professor of Interventional...
Read MoreProf Patrick W. Serruys with respected h-index – 183 is a professor of Interventional Cardiology at the Interuniversity Cardiological Institute of the Netherlands (1988-1998) and Erasmus MC. Since 1980 he was a Director of the Clinical Research Program of the Catheterization Laboratory, Thorax Center at Erasmus University, and till April 1, 2014 (retirement date) the Head of the Interventional Department, Thorax Center, Erasmus MC (University Medical Center Rotterdam), Rotterdam, The Netherlands. Since April 2013, he holds the position of Professor of Cardiology in the Cardiovascular Science Division of the National Heart and Lung Institute (NHLI) at the Faculty of Medicine, within the Imperial College of Science, Technology and Medicine, London.He is a Fellow of the American College of Cardiology and a Fellow of the European Society of Cardiology and scientific council of the International College of Angiology.In 1996, he received the TCT Career Achievement Award and in 1997 he was awarded the Wenkebach Prize of the Dutch Heart Foundation. In 2000, he was awarded the Gruentzig Award of the European Society of Cardiology. In 2001, he held the Paul Dudley White Lecture at the American Heart Association in the USA. In 2004, he received the Andreas Gruentzig Award of the Swiss Society of Cardiology. In 2005, he held the 4th International Lecture at the AHA and Mikamo Lecture at the Japanese heart Association. In 2006, he received the highest award of the Clinical Council of the American Heart Association: the James Herrick Award. In 2007, he received the Arrigo Recordati International Prize (Italy) and the ICI Achievement Award (bestowed by the President of Israel – Shimon Perez). In 2008, he received the Einthoven Penning (Leiden). In 2009, he became Doctor Honoris Causa from the University of Athens. In 2011, he received the Lifetime Achievement Award, bestowed by the American College of Cardiology, in recognition of many years of service and invaluable contributions to the ACC. At the end of 2011, Prof Serruys received the Ray C. Fish Award, bestowed by the Texas Heart Institute, for outstanding achievement and contribution to cardiovascular medicine. In 2012, he received a Golden Medal of the European Society of Cardiology. In 2013, he became Doctor Honoris Causa from the Complutense University of Madrid. In 2016, he became Doctor Honoris Causa of the Melbourne University, Australia. Currently he is established Professor of Interventional Medicine and Innovation at the National University of Ireland, Galway.
Show LessRasha Al-Lamee
Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS...
Read MoreDr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK. Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is the lead author of the primary publication in The Lancet. At Imperial College, she is actively involved in the development and recruitment for a number of multi-centre clinical trials. Dr Al- Lamee has over 40 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career. She studied at the University of Oxford and University College London. She went onto complete her training as a junior doctor on the Barts and the London Medical rotation before being appointed as a Specialist Registrar on the North West London Cardiology rotation in 2006. Dr Al-Lamee has twelve years of Cardiology experience and completed three years of Interventional Fellowship training at Hammersmith Hospital in London. She also spent a year training as an Interventional Fellow under the supervision of Professor Antonio Colombo in Milan. She completed specialist training in Cardiology in 2013.
Show LessRobert Schwartz
Robert Schwartz works at Minneapolis Heart Institute Foundation, Inver Grove Heights, MN, USA.
Read MoreRobert Schwartz works at Minneapolis Heart Institute Foundation, Inver Grove Heights, MN, USA.
Show LessRoberto Diletti
A consultant cardiologist at Thorax Centre Erasmus MS, Rotterdam, The Netherlands. Features in 7...
Read MoreA consultant cardiologist at Thorax Centre Erasmus MS, Rotterdam, The Netherlands. Features in 7 videos on Wondr Medical. Roberto Diletti generally speaks on Fractional Flow Reserve (FFR) and Live Cases.
Show LessSteffen Gloekler
Steffen Gloekler is a cardiologist at Schwarzwald-Baar Klinikum, Bern, Switzerland.
Read MoreSteffen Gloekler is a cardiologist at Schwarzwald-Baar Klinikum, Bern, Switzerland.
Show LessThomas Modine
Thomas Modine graduated from Lille University Hospital, France. He has MD, PhD and MBA degrees...
Read MoreThomas Modine graduated from Lille University Hospital, France. He has MD, PhD and MBA degrees and is a renowned surgeon in TAVI, TMVR, minimally invasive surgery and valve sparing techniques. He is also involved in basic science research programmes and is developing a percutaneous mitral programme with IP. From 2004 to 2006, Thomas completed a PhD thesis and then went on to complete a 1-and-a-half-year fellowship at Harefield Hospital, London. Later he dedicated his training to the development and progress of percutaneous techniques and heart team approach. His research interests are in aortic valve complex, bioengineering, beating heart surgery, hybrid approaches, TAVI and TMVR. Both basic and clinical aspects of research experiences are studied. He is currently working as a consultant cardiac surgeon at Bordeaux University Hospital and professor at Jiao Tong University, Shanghai.
Show LessUlf Landmesser
Ulf Landmesser is a consultant cardiologist at Charite Hospital, Universitätsmedizin Berlin.
Read MoreUlf Landmesser is a consultant cardiologist at Charite Hospital, Universitätsmedizin Berlin.
Show LessVitaly Baystrukov
Vitaly Baystrukov is a cardiologist at EN Meshalkin National Medical Research Centre,...
Read MoreVitaly Baystrukov is a cardiologist at EN Meshalkin National Medical Research Centre, Novosibirsk, Russian Federation.
Show LessZiad Ali
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational...
Read MoreZiad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Show Less